-
1
-
-
24744450543
-
Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets
-
Alsarra, I. A., El-Bagory, I., & Bayomi, M. A. (2005). Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets. Drug Dev. Ind. Pharm., 31, 385-395.
-
(2005)
Drug Dev. Ind. Pharm
, vol.31
, pp. 385-395
-
-
Alsarra, I.A.1
El-Bagory, I.2
Bayomi, M.A.3
-
2
-
-
0018868141
-
Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms
-
Arnold R. R., Brewer, M,, & Gauthier, J. J. (1980). Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun., 28, 893-898.
-
(1980)
Infect. Immun
, vol.28
, pp. 893-898
-
-
Arnold, R.R.1
Brewer, M.2
Gauthier, J.J.3
-
3
-
-
0017389761
-
A bactericidal effect for human lactoferrin
-
Arnold, R. R., Cole, M. F., & McGhee, J. R. (1977). A bactericidal effect for human lactoferrin. Science, 197, 263-265.
-
(1977)
Science
, vol.197
, pp. 263-265
-
-
Arnold, R.R.1
Cole, M.F.2
McGhee, J.R.3
-
4
-
-
0023552869
-
Comparison of albumin and casein microspheres as a carrier for doxorubicin
-
Chen, Y., Willmott, N., Anderson, J., & Florence, A. T. (1987). Comparison of albumin and casein microspheres as a carrier for doxorubicin. J. Pharm. Pharmacol., 39, 978-985.
-
(1987)
J. Pharm. Pharmacol
, vol.39
, pp. 978-985
-
-
Chen, Y.1
Willmott, N.2
Anderson, J.3
Florence, A.T.4
-
5
-
-
0033789005
-
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline
-
Cirioni, O., Giacometti, A., Barchiesi, F., & Scalise, G. (2000). Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J. Antimicrob. Chemother., 46, 577-582.
-
(2000)
J. Antimicrob. Chemother
, vol.46
, pp. 577-582
-
-
Cirioni, O.1
Giacometti, A.2
Barchiesi, F.3
Scalise, G.4
-
6
-
-
0033801238
-
Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice
-
Haversen, L. A., Engberg, I., Baltzer, L., Dolphin, G., Hanson, L. A., & Mattsby-Baltzer, I. (2000). Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun., 68, 5816-5823.
-
(2000)
Infect. Immun
, vol.68
, pp. 5816-5823
-
-
Haversen, L.A.1
Engberg, I.2
Baltzer, L.3
Dolphin, G.4
Hanson, L.A.5
Mattsby-Baltzer, I.6
-
7
-
-
0037139358
-
Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres
-
Hejazi, R., & Amiji, M. (2002) Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int. J. Pharm., 235, 87-94.
-
(2002)
Int. J. Pharm
, vol.235
, pp. 87-94
-
-
Hejazi, R.1
Amiji, M.2
-
8
-
-
0037472115
-
Chitosan-based gastrointestinal delivery systems
-
Hejazi, R., & Amiji, M. (2003). Chitosan-based gastrointestinal delivery systems. J. Control Release, 89, 151-165.
-
(2003)
J. Control Release
, vol.89
, pp. 151-165
-
-
Hejazi, R.1
Amiji, M.2
-
9
-
-
19344377492
-
Evaluation of Eudragitcoated chitosan microparticles as an oral immune delivery system
-
Hori, M., Onishi, H., & Machida, Y. (2005). Evaluation of Eudragitcoated chitosan microparticles as an oral immune delivery system. Int. J. Pharm., 297, 223-234.
-
(2005)
Int. J. Pharm
, vol.297
, pp. 223-234
-
-
Hori, M.1
Onishi, H.2
Machida, Y.3
-
10
-
-
0035999699
-
Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles
-
Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., & Yang, C. (2002). Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, 23, 3193-3201.
-
(2002)
Biomaterials
, vol.23
, pp. 3193-3201
-
-
Hu, Y.1
Jiang, X.2
Ding, Y.3
Ge, H.4
Yuan, Y.5
Yang, C.6
-
11
-
-
0033028757
-
Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
-
Iigo, M., Kuhara, T., Ushida, Y., Sekine, K., Moore, M. A., & Tsuda, H. (1999). Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis, 17, 35-40.
-
(1999)
Clin. Exp. Metastasis
, vol.17
, pp. 35-40
-
-
Iigo, M.1
Kuhara, T.2
Ushida, Y.3
Sekine, K.4
Moore, M.A.5
Tsuda, H.6
-
12
-
-
24944547407
-
Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration
-
Ishikado, A., Imanaka, H., Takeuchi, T., Harada, E., & Makino, T. (2005). Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol. Pharm. Bull., 28, 1717-1721.
-
(2005)
Biol. Pharm. Bull
, vol.28
, pp. 1717-1721
-
-
Ishikado, A.1
Imanaka, H.2
Takeuchi, T.3
Harada, E.4
Makino, T.5
-
13
-
-
29344463703
-
Anti herpes simplex virus activity of lactoferrin/lactoferricin- an example of antiviral activity of antimicrobial protein/peptide
-
Jenssen, H. (2005). Anti herpes simplex virus activity of lactoferrin/lactoferricin- an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci., 62, 3002-3013.
-
(2005)
Cell. Mol. Life Sci
, vol.62
, pp. 3002-3013
-
-
Jenssen, H.1
-
14
-
-
0036001084
-
Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery
-
Kaur, I. P., & Smitha, R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm., 28, 353-369.
-
(2002)
Drug Dev. Ind. Pharm
, vol.28
, pp. 353-369
-
-
Kaur, I.P.1
Smitha, R.2
-
15
-
-
0036177626
-
Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis
-
Kuipers, M. E., Heegsma, J., Bakker, H. I., Meijer, D. K., Swart, P. J., Frijlink, E. W., Eissens, A. C., de Vries-Hospers, H. G., & van den Berg, J. J. (2002). Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv., 9, 31-38.
-
(2002)
Drug Deliv
, vol.9
, pp. 31-38
-
-
Kuipers, M.E.1
Heegsma, J.2
Bakker, H.I.3
Meijer, D.K.4
Swart, P.J.5
Frijlink, E.W.6
Eissens, A.C.7
de Vries-Hospers, H.G.8
van den Berg, J.J.9
-
16
-
-
16544371996
-
Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk
-
Lee, N. Y., Kawai, K., Nakamura, I., Tanaka, T., Kumura, H., & Shimazaki, K. (2004). Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk. J. Vet. Med. Sci., 66, 1267-1269.
-
(2004)
J. Vet. Med. Sci
, vol.66
, pp. 1267-1269
-
-
Lee, N.Y.1
Kawai, K.2
Nakamura, I.3
Tanaka, T.4
Kumura, H.5
Shimazaki, K.6
-
17
-
-
3342888949
-
Lactoferrin and host defence: An overview of its immuno-modulating and anti-inflammatory properties
-
Legrand, D., Elass, E., Pierce, A., & Mazurier, J. (2004). Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals, 17, 225-229.
-
(2004)
Biometals
, vol.17
, pp. 225-229
-
-
Legrand, D.1
Elass, E.2
Pierce, A.3
Mazurier, J.4
-
18
-
-
0036027616
-
In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant
-
Mi, F. L., Tan, Y. C., Liang, H. F., & Sung, H. W. (2002). In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials, 23, 181-191.
-
(2002)
Biomaterials
, vol.23
, pp. 181-191
-
-
Mi, F.L.1
Tan, Y.C.2
Liang, H.F.3
Sung, H.W.4
-
19
-
-
7544224085
-
Mucoadhesive delivery systems. II. Formulation and in-vitro/invivo evaluation of buccal mucoadhesive tablets containing watersoluble drugs
-
Nafee, N. A., Ismail, F. A., Boraie, N. A., & Mortada, L. M. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/invivo evaluation of buccal mucoadhesive tablets containing watersoluble drugs. Drug Dev. Ind. Pharm., 30, 995-1004.
-
(2004)
Drug Dev. Ind. Pharm
, vol.30
, pp. 995-1004
-
-
Nafee, N.A.1
Ismail, F.A.2
Boraie, N.A.3
Mortada, L.M.4
-
20
-
-
3342928851
-
The antimicrobial activity of lactoferrin: Current status and perspectives
-
Orsi, N. (2004). The antimicrobial activity of lactoferrin: current status and perspectives. Biometals, 17, 189-196.
-
(2004)
Biometals
, vol.17
, pp. 189-196
-
-
Orsi, N.1
-
21
-
-
0034827946
-
Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort
-
Samaranayake, Y. H., Samaranayake, L. P., Pow, E. H., Beena, V. T., & Yeung, K. W. (2001). Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J. Clin. Microbiol., 39, 3296-3302.
-
(2001)
J. Clin. Microbiol
, vol.39
, pp. 3296-3302
-
-
Samaranayake, Y.H.1
Samaranayake, L.P.2
Pow, E.H.3
Beena, V.T.4
Yeung, K.W.5
-
22
-
-
3342997837
-
Development of an enteric-coated lactoferrin tablet and its application
-
Shimizu, H. (2004). Development of an enteric-coated lactoferrin tablet and its application. Biometals., 17, 343-347.
-
(2004)
Biometals
, vol.17
, pp. 343-347
-
-
Shimizu, H.1
-
23
-
-
0034862390
-
Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine
-
Shimoda, J., Onishi, H., & Machida, Y. (2001). Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev. Ind. Pharm., 27, 567-576.
-
(2001)
Drug Dev. Ind. Pharm
, vol.27
, pp. 567-576
-
-
Shimoda, J.1
Onishi, H.2
Machida, Y.3
-
24
-
-
28344453346
-
Mammalian lactoferrin receptors: Structure and function
-
Suzuki, Y. A., Lopez, V., & Lonnerdal, B. (2005). Mammalian lactoferrin receptors: structure and function. Cell Mol. Life Sci., 62, 2560-2575.
-
(2005)
Cell Mol. Life Sci
, vol.62
, pp. 2560-2575
-
-
Suzuki, Y.A.1
Lopez, V.2
Lonnerdal, B.3
-
25
-
-
0023748061
-
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
-
Tabata, Y., & Ikada, Y. (1988). Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 9, 356-362.
-
(1988)
Biomaterials
, vol.9
, pp. 356-362
-
-
Tabata, Y.1
Ikada, Y.2
-
26
-
-
0043270528
-
Oral lactoferrin treatment of experimental oral candidiasis in mice
-
Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H., & Abe, S. (2003). Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob. Agents Chemother., 47, 2619-2623.
-
(2003)
Antimicrob. Agents Chemother
, vol.47
, pp. 2619-2623
-
-
Takakura, N.1
Wakabayashi, H.2
Ishibashi, H.3
Teraguchi, S.4
Tamura, Y.5
Yamaguchi, H.6
Abe, S.7
-
27
-
-
0034987135
-
Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases
-
Trif, M., Guillen, C., Vaughan, D. M., Telfer, J. M., Brewer, J. M., Roseanu, A., & Brock, J.H. (2001). Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med., 226, 559-564.
-
(2001)
Exp. Biol. Med
, vol.226
, pp. 559-564
-
-
Trif, M.1
Guillen, C.2
Vaughan, D.M.3
Telfer, J.M.4
Brewer, J.M.5
Roseanu, A.6
Brock, J.H.7
-
28
-
-
0031807119
-
Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds
-
Wakabayashi, H., Abe, S., Teraguchi, S., Hayasawa, H., & Yamaguchi, H. (1998). Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob. Agents Chemother., 42, 1587-1591.
-
(1998)
Antimicrob. Agents Chemother
, vol.42
, pp. 1587-1591
-
-
Wakabayashi, H.1
Abe, S.2
Teraguchi, S.3
Hayasawa, H.4
Yamaguchi, H.5
-
29
-
-
0016227934
-
Iron and susceptibility to infectious disease
-
Weinberg, E. D. (1974). Iron and susceptibility to infectious disease. Science, 184, 952-956.
-
(1974)
Science
, vol.184
, pp. 952-956
-
-
Weinberg, E.D.1
-
30
-
-
0038641842
-
Preparation and characterization of chitosan microspheres containing doxifluridine
-
Yoshino, T., Machida, Y., Onishi, H., & Nagai, T. (2003). Preparation and characterization of chitosan microspheres containing doxifluridine. Drug Dev. Ind. Pharm., 29, 417-427.
-
(2003)
Drug Dev. Ind. Pharm
, vol.29
, pp. 417-427
-
-
Yoshino, T.1
Machida, Y.2
Onishi, H.3
Nagai, T.4
|